Logo image of CREX

CREATIVE REALITIES INC (CREX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CREX - US22530J3095 - Common Stock

2.66 USD
-0.04 (-1.48%)
Last: 12/23/2025, 8:00:01 PM
Fundamental Rating

3

Taking everything into account, CREX scores 3 out of 10 in our fundamental rating. CREX was compared to 94 industry peers in the Media industry. Both the profitability and financial health of CREX have multiple concerns. CREX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CREX had positive earnings in the past year.
In the past year CREX has reported a negative cash flow from operations.
In multiple years CREX reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: CREX reported negative operating cash flow in multiple years.
CREX Yearly Net Income VS EBIT VS OCF VS FCFCREX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

1.2 Ratios

With a Return On Assets value of -1.94%, CREX perfoms like the industry average, outperforming 48.94% of the companies in the same industry.
With a Return On Equity value of -4.19%, CREX perfoms like the industry average, outperforming 53.19% of the companies in the same industry.
Industry RankSector Rank
ROA -1.94%
ROE -4.19%
ROIC N/A
ROA(3y)-2.23%
ROA(5y)-17.47%
ROE(3y)-5.54%
ROE(5y)-80.4%
ROIC(3y)N/A
ROIC(5y)N/A
CREX Yearly ROA, ROE, ROICCREX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

The Gross Margin of CREX (43.41%) is comparable to the rest of the industry.
CREX's Gross Margin has improved in the last couple of years.
CREX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.36%
GM growth 5Y1.66%
CREX Yearly Profit, Operating, Gross MarginsCREX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

CREX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CREX has been increased compared to 1 year ago.
Compared to 5 years ago, CREX has more shares outstanding
CREX has a worse debt/assets ratio than last year.
CREX Yearly Shares OutstandingCREX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CREX Yearly Total Debt VS Total AssetsCREX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

CREX has an Altman-Z score of -0.04. This is a bad value and indicates that CREX is not financially healthy and even has some risk of bankruptcy.
CREX has a worse Altman-Z score (-0.04) than 70.21% of its industry peers.
CREX has a Debt/Equity ratio of 0.68. This is a neutral value indicating CREX is somewhat dependend on debt financing.
CREX has a Debt to Equity ratio (0.68) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Altman-Z -0.04
ROIC/WACCN/A
WACC7.13%
CREX Yearly LT Debt VS Equity VS FCFCREX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

CREX has a Current Ratio of 1.01. This is a normal value and indicates that CREX is financially healthy and should not expect problems in meeting its short term obligations.
CREX has a Current ratio of 1.01. This is comparable to the rest of the industry: CREX outperforms 40.43% of its industry peers.
CREX has a Quick Ratio of 1.01. This is a bad value and indicates that CREX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.93, CREX is doing worse than 61.70% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 0.93
CREX Yearly Current Assets VS Current LiabilitesCREX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

6

3. Growth

3.1 Past

CREX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
Looking at the last year, CREX shows a quite strong growth in Revenue. The Revenue has grown by 12.59% in the last year.
Measured over the past years, CREX shows a quite strong growth in Revenue. The Revenue has been growing by 9.98% on average per year.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2100%
Revenue 1Y (TTM)12.59%
Revenue growth 3Y40.23%
Revenue growth 5Y9.98%
Sales Q2Q%-26.97%

3.2 Future

Based on estimates for the next years, CREX will show a very strong growth in Earnings Per Share. The EPS will grow by 66.98% on average per year.
Based on estimates for the next years, CREX will show a very strong growth in Revenue. The Revenue will grow by 32.68% on average per year.
EPS Next Y-97.82%
EPS Next 2Y66.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.75%
Revenue Next 2Y42.62%
Revenue Next 3Y32.68%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CREX Yearly Revenue VS EstimatesCREX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
CREX Yearly EPS VS EstimatesCREX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2 -3

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 19.00 indicates a rather expensive valuation of CREX.
CREX's Price/Earnings ratio is a bit cheaper when compared to the industry. CREX is cheaper than 71.28% of the companies in the same industry.
CREX is valuated rather cheaply when we compare the Price/Earnings ratio to 26.50, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 10.23 indicates a reasonable valuation of CREX.
73.40% of the companies in the same industry are more expensive than CREX, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.93, CREX is valued rather cheaply.
Industry RankSector Rank
PE 19
Fwd PE 10.23
CREX Price Earnings VS Forward Price EarningsCREX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CREX's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.36
CREX Per share dataCREX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

CREX's earnings are expected to grow with 66.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y66.98%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CREX!.
Industry RankSector Rank
Dividend Yield 0%

CREATIVE REALITIES INC

NASDAQ:CREX (12/23/2025, 8:00:01 PM)

2.66

-0.04 (-1.48%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-12 2025-11-12/bmo
Earnings (Next)03-12 2026-03-12/bmo
Inst Owners15.19%
Inst Owner Change-23.71%
Ins Owners17.24%
Ins Owner Change21.85%
Market Cap27.98M
Revenue(TTM)50.85M
Net Income(TTM)-1.23M
Analysts84
Price Target8.29 (211.65%)
Short Float %0.83%
Short Ratio0.86
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)225.73%
Min EPS beat(2)-149.99%
Max EPS beat(2)601.45%
EPS beat(4)2
Avg EPS beat(4)117.54%
Min EPS beat(4)-149.99%
Max EPS beat(4)601.45%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.64%
Min Revenue beat(2)-11.52%
Max Revenue beat(2)6.23%
Revenue beat(4)3
Avg Revenue beat(4)0.2%
Min Revenue beat(4)-11.52%
Max Revenue beat(4)6.23%
Revenue beat(8)4
Avg Revenue beat(8)-1.96%
Revenue beat(12)4
Avg Revenue beat(12)-3.57%
Revenue beat(16)4
Avg Revenue beat(16)-3.18%
PT rev (1m)13.04%
PT rev (3m)22.64%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-89.69%
EPS NY rev (1m)-724.39%
EPS NY rev (3m)-541.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-19.13%
Revenue NY rev (1m)12.01%
Revenue NY rev (3m)6.38%
Valuation
Industry RankSector Rank
PE 19
Fwd PE 10.23
P/S 0.58
P/FCF N/A
P/OCF N/A
P/B 0.95
P/tB N/A
EV/EBITDA 15.36
EPS(TTM)0.14
EY5.26%
EPS(NY)0.26
Fwd EY9.78%
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS4.58
BVpS2.8
TBVpS-1.78
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.97
Profitability
Industry RankSector Rank
ROA -1.94%
ROE -4.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.41%
FCFM N/A
ROA(3y)-2.23%
ROA(5y)-17.47%
ROE(3y)-5.54%
ROE(5y)-80.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.36%
GM growth 5Y1.66%
F-Score3
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Debt/EBITDA 6.52
Cap/Depr 54.53%
Cap/Sales 5.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.01
Quick Ratio 0.93
Altman-Z -0.04
F-Score3
WACC7.13%
ROIC/WACCN/A
Cap/Depr(3y)115.1%
Cap/Depr(5y)95.1%
Cap/Sales(3y)8.11%
Cap/Sales(5y)6.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2100%
EPS Next Y-97.82%
EPS Next 2Y66.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.59%
Revenue growth 3Y40.23%
Revenue growth 5Y9.98%
Sales Q2Q%-26.97%
Revenue Next Year10.75%
Revenue Next 2Y42.62%
Revenue Next 3Y32.68%
Revenue Next 5YN/A
EBIT growth 1Y-161.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year580.51%
EBIT Next 3Y202.07%
EBIT Next 5YN/A
FCF growth 1Y-268.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-100.91%
OCF growth 3Y93.04%
OCF growth 5YN/A

CREATIVE REALITIES INC / CREX FAQ

Can you provide the ChartMill fundamental rating for CREATIVE REALITIES INC?

ChartMill assigns a fundamental rating of 3 / 10 to CREX.


What is the valuation status for CREX stock?

ChartMill assigns a valuation rating of 4 / 10 to CREATIVE REALITIES INC (CREX). This can be considered as Fairly Valued.


What is the profitability of CREX stock?

CREATIVE REALITIES INC (CREX) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for CREX stock?

The Earnings per Share (EPS) of CREATIVE REALITIES INC (CREX) is expected to decline by -97.82% in the next year.